MEXICO CITY, Jan. 13 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (“Genomma Lab” or “the Company”) announces that based on the main preliminary indicators obtained at the close of the fourth quarter of 2008, the Company expects to report slightly lower results than the original growth expectations. However, product sales at the point of sale continue to be in line with original projections.
Despite favorable acceptance at the point of sale, some of Genomma Lab’s clients chose to marginally reduce inventory levels during the last two weeks of December, in light of the current economic situation.
During the fourth quarter, the Company maintained a strict focus on working capital, placing the Company in a very solid position in terms of liquidity.
Genomma Lab will report fourth quarter results on February 17, 2009, followed by the quarterly conference call, which will take place on the following day.
Company Description
Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.
Genomma Lab’s shares trade on the Mexican Stock Exchange under the ticker symbol “LAB”.
CONTACT: Investor Relations, Genomma Lab, +011-52-55-5081-0000, Ext. 4250,
inversion@genommalab.com; or in New York, i-advize Corporate
Communications, Inc., +1-212-406-3691, +1-212-406-3695,
genomma@i-advize.com, for Genomma Lab
Web site: http://www.genommalab.com/
